
ANAVEX 2-73 Shows Positive Cognitive Effects in 10 Out of 12 Patients
In Phase 2 trials, Anavex performed as much as 4 times better than Aricept®, today’s most popular Alzheimer’s medication. The pill achieved cognitive and functional
In Phase 2 trials, Anavex performed as much as 4 times better than Aricept®, today’s most popular Alzheimer’s medication. The pill achieved cognitive and functional
CBS VIDEO + ARTICLE: Excitement and Hope are 2 words not often heard in Alzheimer’s clinical trials, but new results for solanezumab are generating quite
150 Alzheimer’s clinical trials are looking for volunteers in the USA. They are trying out the newest drugs and therapies on 70,000 people with various
VIDEO: “For the first time I think we have a chance to really change the course of Alzheimer’s disease,” says Dr. Reisa Sperling. She’s leading
VIDEO & ARTICLE: CNBC’s Meg Tirrell reports on Biogen’s experimental drug for Alzheimer’s and how the company appears to have exceeded expectations.
VIDEOS + ARTICLE: Renowned model, actress and restauranteur B. Smith and her husband, Dan Gasby, talk about life with Alzheimer’s. See her new video to
VIDEO + ARTICLE: The A4 Study is a cutting-edge trial aimed at preventing Alzheimer’s. The clinical trial is testing healthy adults who are at risk
VIDEO + ARTICLE: The simple SAPPHIRE Eye Test has the potential to change the way that Alzheimer’s disease is detected and managed. Made by Cognoptix, see
VIDEO + ARTICLE: Solanezumab is a maturing experimental vaccine that dissolves Alzheimer’s plaque. Find out why neurologists are excited about its performance in Alzheimer’s and
POTENTIAL TREATMENT: “Pre-dementia” is a common nickname for aMCI (amnestic Mild Cognitive Impairment). aMCI causes memory to decline more than what’s expected from normal aging,
See why Leqembi is even more effective in males than females, at fighting Alzheimer’s.
Stanford Medicine’s new analysis of a vaccination program found shingles vaccines appear to lower dementia diagnoses by 20% — more than any other known intervention.
The big Alzheimer’s culprits are Amyloid and Tau. Biogen made Leqembi to treat amyloid. Now, they are betting on BIIB080 to treat tau. Learn how this exciting new treatment just got FDA Fast Track Designation.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.